TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 4 | -0 | 1 | -4 | 4 | -20 | -41 | -10 |
P | %wins | 50 | 75 | 50 | 50 | 25 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/08 13:11 | 5/30/08 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Richard M | WA | O | CFO | P | 5 | 1.10 | 5 | 5 | 22 | 28 | I | -55 | -55 | -49 | -37 | -40 | 6 | 4 | 2 | -1 | 5 | 4 | 33 | -18 | -25 |
12/12/07 16:00 | 12/10/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Richard M | WA | O | CFO | P.dm | 5 | 1.23 | 5 | 4 | 22 | 23 | I | -13 | 14 | -23 | -20 | -25 | -11 | -6 | -6 | 2 | 3 | -10 | -15 | -33 | -46 |
12/7/07 13:41 | 12/6/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Richard M | WA | O | CFO | P.m | 5 | 1.34 | 5 | 4 | 27 | 19 | I | -4 | 16 | -12 | -12 | -17 | -8 | 0 | 2 | 0 | -9 | -21 | -27 | -44 | -66 |
3/16/07 15:28 | 3/16/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Richard M | WA | O | CFO | P | 33 | 2.25 | 4 | 15 | New | 15 | I | 0 | -20 | 14 | 29 | -5 | -7 | -10 | -3 | -2 | 3 | 12 | 24 | 15 | -27 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |